Yes, completely free. QuickRx Specialty Pharmacy provides free enrollment and support for all treprostinil copay assistance programs including Remodulin, Tyvaso, and Orenitram copay cards and patient assistance programs. We never charge service fees for helping patients access medication savings.

What’s included at no cost:

• Application assistance for treprostinil manufacturer copay cards (Remodulin, Tyvaso, Orenitram)
• Insurance verification and benefit checks for PAH medications
• Prior authorization support when needed
• Foundation grant applications for pulmonary arterial hypertension treatment
• Ongoing monitoring to ensure continuous savings
• Prescription coordination and specialty medication delivery

Treprostinil savings programs available:

For patients with commercial insurance, manufacturer copay cards for Remodulin, Tyvaso, and Orenitram can significantly reduce your out-of-pocket costs for treprostinil treatment.

For Medicare and Medicaid patients, foundation-based assistance programs provide grants that help cover PAH medication expenses. These programs are also free to apply for with QuickRx’s help.

For uninsured patients, manufacturer patient assistance programs may provide treprostinil medications at no cost or significantly reduced prices based on financial need.

Our team’s only goal is to make treprostinil more affordable so you can focus on managing your pulmonary arterial hypertension without financial stress. Contact QuickRx at (917) 830-2525 or (800) 496-6111 to get started today.

Eligibility for treprostinil copay assistance depends on your insurance type, the specific treprostinil medication you’re prescribed (Remodulin, Tyvaso, or Orenitram), and your financial situation. QuickRx helps determine which programs you qualify for at no cost.

Eligibility criteria for treprostinil copay cards:

Commercial insurance patients with coverage for treprostinil medications typically qualify for manufacturer copay cards. Requirements usually include:

• Active commercial (private) health insurance that covers treprostinil
• Valid prescription for Remodulin, Tyvaso, or Orenitram
• Treatment for FDA-approved pulmonary arterial hypertension (PAH) indication
• Age 18 or older (some programs have different age requirements)
• US residency

Alternative assistance for other insurance types:

Medicare and Medicaid patients cannot use manufacturer copay cards due to federal regulations, but may qualify for foundation grants and other patient assistance programs specifically designed for government insurance beneficiaries.

Uninsured patients may qualify for manufacturer patient assistance programs that provide free or low-cost treprostinil based on household income and financial need.

How QuickRx determines your eligibility:

When you contact QuickRx, we review your insurance coverage, prescription details, and financial situation to identify every treprostinil assistance program you qualify for. We then handle all applications and enrollment paperwork on your behalf.

Call (917) 830-2525 or (800) 496-6111 to speak with a copay assistance specialist who can verify your eligibility for treprostinil savings programs today.

Savings vary by insurance type, specific treprostinil medication (Remodulin, Tyvaso, or Orenitram), and the assistance programs you qualify for. QuickRx works to maximize your savings through all available programs.

Potential treprostinil copay assistance savings:

With commercial insurance, manufacturer copay cards can significantly reduce out-of-pocket costs for treprostinil medications. The amount of savings depends on your insurance plan’s copay or coinsurance amount and the specific program benefit limits.

With Medicare or Medicaid, foundation grants and patient assistance programs help cover medication costs that Medicare doesn’t pay. Grant amounts vary by foundation and availability of funds.

For uninsured patients, manufacturer patient assistance programs may provide treprostinil at no cost if you meet income eligibility requirements.

Why savings amounts vary:

The cost of treprostinil medications like Remodulin, Tyvaso, and Orenitram can be substantial without assistance. Your actual savings depend on:

• Your insurance plan’s coverage and cost-sharing structure
• Whether your medication requires specialty pharmacy dispensing
• Annual benefit caps on copay assistance programs
• Foundation funding availability at the time of application
• Your household income (for patient assistance programs)

QuickRx maximizes your savings:

Our specialty in pulmonary arterial hypertension medications means we know how to layer multiple assistance programs to achieve maximum savings on your treprostinil prescriptions. We monitor your benefits throughout the year and handle renewals to ensure uninterrupted assistance.

Contact QuickRx at (917) 830-2525 or (800) 496-6111 to find out exactly how much you can save on your specific treprostinil medication.

Yes, Medicare patients can access treprostinil financial assistance, but not through manufacturer copay cards. Medicare beneficiaries may qualify for foundation grants and other patient assistance programs specifically designed to help cover out-of-pocket costs for pulmonary arterial hypertension medications.

Why Medicare patients can’t use copay cards:

Federal anti-kickback laws prohibit pharmaceutical manufacturers from offering copay cards to Medicare and Medicaid beneficiaries. This applies to all treprostinil medications including Remodulin, Tyvaso, and Orenitram.

Alternative assistance for Medicare patients:

QuickRx connects Medicare patients with alternative treprostinil assistance programs including:

• Independent charitable foundations that provide grants for PAH medications
• Disease-specific foundations focused on pulmonary arterial hypertension
• Manufacturer patient assistance programs for qualifying patients
• State pharmaceutical assistance programs (SPAPs) where available

How QuickRx helps Medicare patients:

Our team specializes in navigating the complex landscape of Medicare Part D coverage for specialty medications like treprostinil. We help you:

• Understand your Medicare Part D plan’s coverage for Remodulin, Tyvaso, or Orenitram
• Apply for foundation grants to cover copays, coinsurance, and deductibles
• Navigate the Medicare donut hole (coverage gap)
• Complete patient assistance program applications if you qualify
• Monitor assistance programs year-round and handle renewals

Don’t let Medicare restrictions prevent you from affording your treprostinil medication. Call QuickRx at (917) 830-2525 or (800) 496-6111 to explore all available assistance options.

Yes, Medicare patients can access treprostinil financial assistance, but not through manufacturer copay cards. Medicare beneficiaries may qualify for foundation grants and other patient assistance programs specifically designed to help cover out-of-pocket costs for pulmonary arterial hypertension medications.

Why Medicare patients can’t use copay cards:

Federal anti-kickback laws prohibit pharmaceutical manufacturers from offering copay cards to Medicare and Medicaid beneficiaries. This applies to all treprostinil medications including Remodulin, Tyvaso, and Orenitram.

Alternative assistance for Medicare patients:

QuickRx connects Medicare patients with alternative treprostinil assistance programs including:

• Independent charitable foundations that provide grants for PAH medications
• Disease-specific foundations focused on pulmonary arterial hypertension
• Manufacturer patient assistance programs for qualifying patients
• State pharmaceutical assistance programs (SPAPs) where available

How QuickRx helps Medicare patients:

Our team specializes in navigating the complex landscape of Medicare Part D coverage for specialty medications like treprostinil. We help you:

• Understand your Medicare Part D plan’s coverage for Remodulin, Tyvaso, or Orenitram
• Apply for foundation grants to cover copays, coinsurance, and deductibles
• Navigate the Medicare donut hole (coverage gap)
• Complete patient assistance program applications if you qualify
• Monitor assistance programs year-round and handle renewals

Don’t let Medicare restrictions prevent you from affording your treprostinil medication. Call QuickRx at (917) 830-2525 or (800) 496-6111 to explore all available assistance options.

Treprostinil is a prescription medication used to treat pulmonary arterial hypertension (PAH), a serious condition where blood pressure in the arteries of the lungs becomes abnormally high. The medication helps improve exercise ability and slow disease progression in PAH patients.

How treprostinil works for PAH:

Treprostinil is a prostacyclin analog that works by dilating (widening) the pulmonary arteries and reducing the workload on the heart. This helps:

• Lower blood pressure in the pulmonary arteries
• Improve blood flow through the lungs
• Reduce strain on the right side of the heart
• Increase exercise capacity and reduce symptoms

Common treprostinil brand names:

Remodulin is given as a continuous infusion under the skin (subcutaneously) or into a vein (intravenously) using a small pump.

Tyvaso is breathed in through the lungs using an inhalation system, available as both a liquid nebulizer solution and a dry powder inhaler (Tyvaso DPI).

Orenitram is taken by mouth as an extended-release tablet, usually with food.

Yutrepia is another inhaled formulation using dry powder capsules breathed into the lungs with a special device.

Importance of continuous treprostinil therapy:

Pulmonary arterial hypertension is a progressive disease that requires ongoing treatment. Suddenly stopping treprostinil can cause a dangerous worsening of PAH symptoms including severe shortness of breath, dizziness, and weakness.

That’s why affordable access to your treprostinil medication is critical. QuickRx Specialty Pharmacy helps ensure you can afford continuous treatment through copay assistance programs. Call (917) 830-2525 or (800) 496-6111 for help accessing treprostinil.

Treprostinil is available in four different formulations, each designed for a specific method of administration. Your doctor will prescribe the form that best suits your PAH treatment needs and lifestyle.

Treprostinil infusion (Remodulin):

Subcutaneous infusion: Given continuously into the fatty part of the skin using a small portable infusion pump. This is the most common form of treprostinil.

Intravenous infusion: Given continuously into a vein through a central line catheter and portable pump. This method is used when subcutaneous infusion is not tolerated or suitable.

Both infusion methods provide 24-hour continuous medication delivery. Your doctor or nurse will teach you how to operate the pump and manage the infusion site.

Treprostinil for inhalation:

Tyvaso liquid for nebulizer: Breathed into the lungs four times daily using the Tyvaso Inhalation System. Each treatment takes several minutes using the specialized nebulizer device.

Tyvaso DPI (dry powder inhaler): Breathed into the lungs four times daily using disposable cartridges inserted into the Tyvaso DPI inhaler device. This is a more portable option than the liquid nebulizer.

Yutrepia capsules for inhalation: Dry powder capsules that are loaded one at a time into a special inhaler device and breathed into the lungs. The capsules are not swallowed.

Treprostinil tablets (Orenitram):

Extended-release tablets taken by mouth with food, usually starting with twice-daily dosing. The tablets must be swallowed whole and cannot be chewed, broken, or crushed. The tablet shell does not dissolve and may appear in your stool, which is normal.

Storage requirements vary by form:

Each treprostinil formulation has specific storage requirements. Infusion solutions must be protected from light, inhaled forms require specific temperature storage, and tablets should be stored at room temperature in a dry place.

QuickRx Specialty Pharmacy provides detailed instructions for storing and using your specific treprostinil medication. We also coordinate delivery of pumps, nebulizers, and other supplies needed for your treatment.

How you take treprostinil depends on which formulation your doctor prescribed. Each form has specific administration instructions that must be followed exactly. Never stop taking treprostinil suddenly without calling your doctor.

Taking treprostinil infusion (Remodulin):

Infusions are given continuously (24 hours a day, non-stop) either under the skin or into a vein. Your doctor or nurse will teach you:

• How to operate your portable infusion pump
• How to change infusion sites for subcutaneous delivery
• How to mix the medication if needed
• How to recognize and respond to pump malfunctions
• Always keep a backup pump system available in case your primary pump fails

Important safety tips for infusions:

• Wash your hands before and after handling the infusion system
• Do not use if solution is cloudy, leaking, has particles, or has changed color
• If you notice signs of withdrawal or think the pump isn’t working, get medical help immediately
• Proper central line care is critical to prevent serious bloodstream infections

Taking treprostinil for inhalation (Tyvaso, Yutrepia):

Tyvaso liquid nebulizer: Breathe into lungs only using the Tyvaso inhalation system, four times daily. Discard any medication left in the chamber after your last dose each day. Never mix other drugs in the nebulizer.

Tyvaso DPI: Follow your doctor’s instructions on dosing frequency. Let refrigerated cartridges reach room temperature for at least 10 minutes before use. Store the empty inhaler with mouthpiece attached. Never wash or rinse the inhaler – wipe outside only with a dry cloth.

Yutrepia capsules: Use only the device that comes with Yutrepia. Never swallow the capsules – the contents must be breathed into the lungs. Keep your hands dry when handling. Only remove capsules from blister pack when ready to use. Inhale contents within 5 minutes of opening the blister. Do not wash the device – keep the mouthpiece dry.

Taking treprostinil tablets (Orenitram):

Take with food. Swallow tablets whole – do not chew, break, or crush. Do not take chipped or broken tablets. If you miss doses for more than 5 days in a row, ask your doctor before starting again. If you miss 2 doses, call your doctor for guidance.

What to do if you miss a dose:

For infusions: Call your doctor immediately to find out what to do.

For inhalation forms: Take the missed dose as soon as you remember. If it’s close to your next dose, skip the missed dose and return to your normal schedule. Never take 2 doses at the same time.

For tablets: Take the missed dose with food as soon as you remember. If it’s close to your next dose, skip it and return to your normal time. Never double up.

For detailed administration training and ongoing support with your treprostinil medication, contact QuickRx at (917) 830-2525 or (800) 496-6111.

All forms of treprostinil can cause side effects, though many patients experience only minor effects that improve over time. Contact your doctor if side effects bother you or don’t go away.

Common side effects (all forms):

• Dizziness or headache
• Flushing (redness and warmth of the skin)
• Jaw pain
• Diarrhea, upset stomach, or nausea/vomiting

Additional side effects specific to tablets (Orenitram):

• Pain in arms or legs
• Stomach pain
• Seeing the tablet shell in your stool (this is normal and not a concern)
• Low potassium levels causing muscle pain, weakness, cramps, or abnormal heartbeat

Additional side effects specific to infusions (Remodulin):

• Pain and irritation where the medication goes into the body
• Irritation at injection site
• Arm swelling
• Burning, numbness, or tingling sensations
• Anxiety or restlessness

Additional side effects specific to inhalation forms (Tyvaso, Yutrepia):

• Cough
• Throat irritation
• Muscle pain (liquid nebulizer)
• Bone pain (liquid nebulizer)

Serious side effects requiring immediate medical attention:

Call your doctor or get medical help right away if you have:

• Signs of allergic reaction: rash, hives, itching, swollen or peeling skin, wheezing, chest tightness, trouble breathing or swallowing, swelling of mouth/face/lips/tongue/throat
• Signs of bleeding: vomiting or coughing up blood, blood in urine, black/red/tarry stools, bleeding from gums, abnormal vaginal bleeding, unexplained bruises, bleeding you cannot stop
• Severe dizziness or passing out
• Shortness of breath, significant weight gain, or swelling in arms or legs
• New or worsening trouble breathing

Managing treprostinil side effects:

Your doctor may adjust your dose to reduce side effects. Never change your dose or stop taking treprostinil without medical guidance, as suddenly stopping can dangerously worsen PAH symptoms.

No, never stop taking treprostinil suddenly. Pulmonary arterial hypertension requires continuous treatment even when you feel better. Suddenly stopping treprostinil can cause a rapid and dangerous worsening of PAH symptoms.

Why continuous treprostinil therapy is critical:

Even if you’re feeling better and your symptoms have improved, this means the medication is working to control your pulmonary arterial hypertension. PAH is a progressive disease that doesn’t go away – it requires ongoing treatment to keep blood pressure in your lungs under control.

Dangers of suddenly stopping treprostinil:

Abruptly discontinuing treprostinil can cause:

• Sudden worsening of shortness of breath
• Severe dizziness or fainting
• Dangerous increase in pulmonary artery pressure
• Increased strain on your heart
• Life-threatening complications

When medication changes are needed:

If you’re experiencing problems with your treprostinil medication, talk with your doctor before making any changes. They can:

• Adjust your dose to reduce side effects
• Switch you to a different treprostinil formulation (infusion, inhalation, or tablet)
• Add other PAH medications to your treatment regimen
• Help you manage any side effects you’re experiencing

If cost is preventing you from taking treprostinil:

Don’t stop taking your medication because of cost concerns. QuickRx Specialty Pharmacy can help you access copay assistance programs for Remodulin, Tyvaso, or Orenitram to make your treatment affordable.

Before starting treprostinil (Remodulin, Tyvaso, Orenitram, or Yutrepia), have an honest conversation with your doctor about your complete medical history and all medications you’re currently taking. This helps prevent dangerous drug interactions and complications.

Tell your doctor if you:

• Are allergic to treprostinil or any part of the medication formulation
• Are allergic to any other drugs, foods, or substances
• Have liver disease
• Are pregnant, planning to become pregnant, or are breast-feeding
• Are 65 or older (you may have more side effects)
• Have diverticulosis if taking Orenitram tablets (the tablet shell doesn’t dissolve)

Provide a complete medication list:

Tell your doctor and pharmacist about ALL medications you take, including:

• Prescription medications
• Over-the-counter (OTC) drugs
• Natural products and supplements
• Vitamins and herbal remedies

Your doctor needs this information to check for potential drug interactions before starting treprostinil.

Important medication interactions:

Treprostinil can interact with medications that affect blood clotting or blood pressure. Be especially sure to mention if you’re taking:

• Blood thinners or anticoagulants
• Other blood pressure medications
• Diuretics (water pills)
• Other PAH medications

Questions to ask your doctor:

Before starting treprostinil, make sure you understand:

• Why this specific form of treprostinil was chosen for you
• How to properly take or administer your medication
• What side effects to watch for and when to call for help
• How to store your medication and supplies properly
• When to schedule follow-up appointments for monitoring
• What to do if you miss a dose or your pump malfunctions
• How to access copay assistance to afford your medication

QuickRx Specialty Pharmacy works closely with PAH specialists to coordinate your treprostinil therapy. We provide ongoing medication counseling and can answer questions about drug interactions, side effects, and proper administration.

Treprostinil requires careful management to ensure safe and effective treatment of pulmonary arterial hypertension. Follow these precautions while taking any form of treprostinil.

Bleeding precautions for all patients:

Treprostinil may increase your risk of bleeding. Be careful and avoid injury:

• Use a soft toothbrush
• Use an electric razor instead of a blade
• Be cautious with sharp objects
• Avoid activities with high injury risk
• Tell your dentist and all healthcare providers that you take treprostinil before any procedures

Dizziness and falling prevention:

Treprostinil can cause dizziness or lightheadedness:

• Rise slowly from sitting or lying down positions
• Be careful when using stairs
• Avoid driving or operating machinery until you know how treprostinil affects you
• Don’t perform tasks requiring alertness if you feel dizzy

Special precautions for infusions (Remodulin):

Infection prevention is critical:

• Always wash hands before and after handling your infusion system
• Keep infusion sites and central line areas clean
• Watch for signs of infection at infusion sites
• Central line infections can be deadly – report fever, redness, or pain immediately

Always have backup systems ready:

• Keep a backup infusion pump nearby at all times
• Know how to switch to your backup pump
• Have emergency contact numbers readily available
• If you think your pump isn’t working properly, get medical help immediately

Special precautions for tablets (Orenitram):

• Always take with food
• Never chew, crush, or break tablets
• Don’t take damaged tablets
• Store in a dry place, not in the bathroom

Special precautions for inhalation forms:

For Tyvaso liquid nebulizer:

• Always have a backup inhalation system available
• Store unopened pouches in foil packaging
• Discard opened pouches after 7 days
• If medication gets in eyes or on skin, rinse with water

For Tyvaso DPI and Yutrepia:

• Keep hands completely dry when handling
• Never wash the inhaler – keep it dry at all times
• Replace inhaler after 7 days of use
• Store properly according to instructions (some need refrigeration)

Tell all healthcare providers:

Inform all doctors, nurses, pharmacists, dentists, and other healthcare providers that you take treprostinil. This is especially important before any surgeries, dental work, or other medical procedures.

Proper storage of treprostinil is essential to maintain medication effectiveness and safety. Storage requirements vary by formulation, so follow the specific instructions for your prescribed product.

Storing treprostinil infusion (Remodulin):

Unopened vials:

• Store at room temperature
• Protect from light exposure
• Store in a dry place, never in a bathroom

After opening or mixing:

• Follow your pharmacist’s specific instructions for storage duration
• Note the expiration date after mixing with fluids
• Keep protected from light even after opening

Storing treprostinil for inhalation:

Tyvaso liquid nebulizer:

• Store unopened containers in foil pouch until use
• Keep at room temperature in a dry place
• Protect from light
• Discard any unused portion of opened pouch after 7 days

Tyvaso DPI inhaler cartridges:

• Unopened blister cards or strips: Store in refrigerator
• May also store unopened at room temperature for up to 8 weeks
• Once stored at room temperature, do NOT put back in refrigerator
• Opened blister strips: Store at room temperature, do not refrigerate
• Discard opened strips if not used within 3 days

Tyvaso DPI empty inhaler device:

• Store empty inhaler in refrigerator or at room temperature
• Discard and replace with new inhaler after 7 days of use

Yutrepia capsules for inhalation:

• Keep capsules in the original blister pack
• Store at room temperature in a dry place
• Do not remove capsules from blister pack until ready to use
• Discard empty inhaler device after 7 days of use
• Do not eat or swallow the desiccant packet if included

Storing treprostinil tablets (Orenitram):

• Store at room temperature
• Keep in a dry place, not in the bathroom
• Moisture can damage extended-release tablets

General storage safety for all forms:

• Keep all medications in a safe place
• Store out of reach of children and pets
• Never use expired medication
• Do not flush down toilet or pour down drain
• Check with your pharmacist about proper disposal
• Ask about drug take-back programs in your area

Travel considerations:

If you need to travel with treprostinil, contact QuickRx Specialty Pharmacy for guidance on:

• Portable storage solutions for your specific formulation
• Temperature control during travel
• Backup systems for infusion patients
• Coordinating medication refills while away
• Documentation for airport security

Pulmonary arterial hypertension (PAH) is the serious medical condition that treprostinil is prescribed to treat. Understanding PAH helps patients better manage their treatment and recognize when to seek medical attention.

What happens in pulmonary arterial hypertension:

PAH is a type of high blood pressure that specifically affects the arteries in your lungs (pulmonary arteries). In PAH:

• The small arteries in your lungs become narrowed, blocked, or destroyed
• This makes it harder for blood to flow through your lungs
• Your heart must work harder to pump blood through the narrowed pulmonary arteries
• Over time, this extra workload weakens the right side of your heart

Common symptoms of PAH:

• Shortness of breath, especially during physical activity
• Fatigue and weakness
• Dizziness or fainting spells
• Chest pain or pressure
• Swelling in ankles, legs, or abdomen
• Bluish color to lips or skin
• Racing heartbeat or heart palpitations
• Reduced ability to exercise

Why PAH is serious:

If left untreated, pulmonary arterial hypertension progressively worsens and can lead to:

• Right-sided heart failure
• Severe disability
• Life-threatening complications

How treprostinil helps PAH:

Treprostinil treats PAH by:

• Dilating (widening) the pulmonary arteries
• Reducing blood pressure in the lungs
• Decreasing the workload on the right side of the heart
• Improving blood flow and oxygen delivery
• Enhancing exercise capacity and reducing symptoms

The importance of continuous treatment:

PAH is a chronic, progressive disease that requires ongoing medication therapy. Even when symptoms improve with treprostinil treatment, the underlying condition remains and the medication must be continued.

Regular monitoring is essential:

PAH patients taking treprostinil need regular follow-up appointments to:

• Monitor pulmonary artery pressure
• Assess heart function
• Evaluate exercise capacity
• Adjust medication doses as needed
• Watch for complications or side effects

Living with PAH:

While PAH is serious, proper treatment with medications like treprostinil can help patients:

• Improve symptoms and quality of life
• Increase exercise tolerance
• Slow disease progression
• Reduce hospitalizations
• Maintain independence longer

QuickRx Specialty Pharmacy specializes in pulmonary arterial hypertension medications and provides comprehensive support for PAH patients. Our team understands the complexity of PAH treatment and works to ensure you can afford your treprostinil therapy.

Get medical help immediately if you suspect pump malfunction or experience withdrawal symptoms. For patients using treprostinil infusions (Remodulin), a malfunctioning pump is a medical emergency because it can lead to dangerous withdrawal symptoms.

Signs of treprostinil withdrawal:

If your infusion pump stops working properly, you may experience:

• Sudden worsening of shortness of breath
• Severe dizziness or lightheadedness
• Extreme weakness or fatigue
• Chest pain or pressure
• Racing or irregular heartbeat
• Anxiety or restlessness
• Feeling like your PAH symptoms are rapidly getting worse

What to do immediately:

Step 1: Call for emergency medical help

• Call 911 or your local emergency number
• Tell them you’re on continuous treprostinil infusion for PAH
• Explain that your pump may have malfunctioned

Step 2: Contact your doctor

• Call your PAH specialist or the on-call physician immediately
• Report your symptoms and pump concerns
• Follow their instructions carefully

Step 3: Switch to your backup pump if possible

• If you’re trained and able, switch to your backup infusion system
• Keep your backup pump and supplies readily accessible at all times
• Make sure your backup pump is properly maintained and ready to use

Preventing pump problems:

To minimize the risk of pump malfunction:

• Follow all manufacturer instructions for pump maintenance
• Check your pump regularly for proper operation
• Keep batteries fresh and have spares available
• Protect your pump from water, extreme temperatures, and physical damage
• Never let your medication reservoir run empty
• Watch for alarms or error messages and respond immediately
• Have your backup system tested and ready at all times

Regular pump maintenance:

Your infusion pump requires routine care:

• Clean external surfaces as directed (never get internal components wet)
• Check tubing for kinks, cracks, or disconnections
• Verify infusion site is intact and not leaking
• Ensure medication is flowing at the correct rate
• Replace batteries before they’re depleted
• Keep spare supplies on hand (tubing, batteries, etc.)

When to seek non-emergency help:

Contact your doctor or QuickRx Specialty Pharmacy during regular hours if you notice:

• Pump alarms or unusual sounds
• Difficulty programming the pump
• Questions about proper pump operation
• Need for pump supplies or replacement equipment
• Concerns about infusion site irritation or pain

QuickRx support for infusion patients:

QuickRx Specialty Pharmacy provides:

• 24/7 pharmacist support for pump-related questions
• Coordination of pump supplies and maintenance
• Training refreshers as needed
• Assistance obtaining backup pump systems
• Emergency medication supply coordination

Treprostinil use during pregnancy and breastfeeding requires careful consideration. You must discuss the risks and benefits with your doctor if you are pregnant, planning to become pregnant, or are breastfeeding.

Treprostinil during pregnancy:

Pulmonary arterial hypertension can worsen during pregnancy and pose serious risks to both mother and baby. However, the effects of treprostinil on pregnancy are not fully understood.

Important considerations:

• Tell your doctor immediately if you become pregnant while taking treprostinil
• If you’re planning to become pregnant, discuss this with your PAH specialist first
• Your doctor will weigh the potential benefits of treatment against possible risks
• Stopping treprostinil suddenly during pregnancy could be dangerous
• You may need more frequent monitoring during pregnancy

Treprostinil while breastfeeding:

It’s not known whether treprostinil passes into breast milk or how it might affect a nursing infant. Your doctor needs to know if you’re breastfeeding or planning to breastfeed.

Factors your doctor will consider:

• The severity of your PAH and need for continuous treatment
• Alternative feeding options for your baby
• Potential risks to your infant from medication exposure
• Risks to your health if treatment is interrupted

Birth control considerations:

Women of childbearing age taking treprostinil should discuss birth control options with their doctor, especially if pregnancy poses significant health risks due to PAH.

Male patients with partners who can become pregnant:

Men taking treprostinil whose partners can become pregnant should use effective contraception during treatment and for 3 months after the last dose, as some treprostinil formulations may cause fetal harm.

Importance of open communication:

Be honest with your healthcare team about:

• Whether you’re pregnant or suspect you might be pregnant
• Plans to become pregnant in the future
• Whether you’re currently breastfeeding
• Any concerns about fertility or family planning

QuickRx support for women’s health concerns:

QuickRx Specialty Pharmacy provides confidential counseling on:

• Medication safety during pregnancy and breastfeeding
• Coordinating with your OB/GYN and PAH specialist
• Managing medication therapy during pregnancy
• Accessing copay assistance for treprostinil during this time

The medical information about Remodulin (treprostinil) on this page is for educational purposes only and is sourced from:

• U.S. Food and Drug Administration (FDA) approved prescribing information for Remodulin (treprostinil injection)
• FDA approved prescribing information for Tyvaso (treprostinil inhalation solution)
• FDA approved prescribing information for Tyvaso DPI (treprostinil inhalation powder)
• FDA approved prescribing information for Orenitram (treprostinil extended-release tablets)
• FDA approved prescribing information for Yutrepia (treprostinil inhalation powder)
• UpToDate clinical drug information database
• Peer-reviewed pulmonary hypertension medical literature

This information is not intended to replace professional medical advice from your doctor or healthcare provider. Always consult your PAH specialist or pharmacist for guidance about your specific treprostinil treatment.

For questions about Remodulin (treprostinil) copay assistance programs or financial help with Tyvaso (treprostinil), Orenitram (treprostinil), or Yutrepia (treprostinil), contact QuickRx Specialty Pharmacy at (917) 830-2525 or (800) 496-6111.

Last reviewed: November 2025